2022
DOI: 10.1016/j.bbamcr.2022.119243
|View full text |Cite
|
Sign up to set email alerts
|

The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(37 citation statements)
references
References 242 publications
0
31
0
Order By: Relevance
“…Our results indicated that the virus can utilize other cathepsins or lysosomal proteases to infect neurons when cathepsin L is inhibited. For example, cathepsin B can also be involved in SARS-CoV-2 entry ( 35 ), and this protein is abundantly expressed in human neurons and neuron-like cells ( 43 ).…”
Section: Resultsmentioning
confidence: 99%
“…Our results indicated that the virus can utilize other cathepsins or lysosomal proteases to infect neurons when cathepsin L is inhibited. For example, cathepsin B can also be involved in SARS-CoV-2 entry ( 35 ), and this protein is abundantly expressed in human neurons and neuron-like cells ( 43 ).…”
Section: Resultsmentioning
confidence: 99%
“…We next used IHC to probe cathepsin D and cathepsin B, the two major lysosomal proteases that are involved in proteolysis of tau and other neurodegenerative proteins 38,39 . We found no significant change of either cathepsin D or cathepsin B immunoreactivity in any area including dorsal and ventral hippocampus and amygdala (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…In the endosomes of immune cells, they participate in both the innate and adaptative immune responses [ 32 , 33 , 34 , 35 , 36 ]. Deregulation of the expression or activity of cathepsins in the endolysosomes leads to impaired degradation of organelle cargos, resulting in the accumulation of substrates that may be responsible for various pathological conditions [ 3 , 8 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 ]. These conditions include lysosomal storage diseases (LSD) such as neuronal ceroid lipofuscinosis [ 37 ]; galactosidases [ 38 ]; mucopolysaccharidoses [ 39 ] and Gaucher disease [ 40 ]; Alzheimer’s [ 41 , 42 ]; Parkinson’s and Huntington’s diseases [ 43 ]; type I diabetes [ 44 ]; auto-immune diseases [ 3 ]; and others [ 8 ].…”
Section: Classification Synthesis Cellular Localization and Physiopat...mentioning
confidence: 99%